(1)
PHARMACOKINETIC VARIABILITY AND THERAPEUTIC DRUG MONITORING OF SYSTEMIC ANTIFUNGAL AGENTS: MITIGATING HEPATOTOXICITY AND OPTIMIZING EFFICACY IN CRITICALLY ILL COHORTS. Wor.Bul.Pub.Helt. 2026, 56, 85-88.